It has not been shown that COVID-19 vaccines cause or accelerate cancer. Yet opponents of the vaccines say a new review ...
The ministry also encouraged all who are aged 6 months and above to get vaccinated a year after their last dose. Read more at ...
Vermont has the second lowest state fatality rate in the US (132.8 per 100K; Hawaii 104.3/100K). Mississippi (448.1/100K) and Oklahoma (445.3/100K) have the highest rates. The US average is 297.9/100K ...
Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...
Pfizer (NYSE:PFE) shares trended higher premarket Wednesday ... Comirnaty vaccine marketed with BIoNTech (NASDAQ:BNTX) added $354M in revenue with a ~88% drop while COVID-19 pill Paxlovid generated $2 ...
(RTTNews) - While reporting financial results for the first quarter, drug major Pfizer Inc. (PFE) raised its adjusted earnings guidance for the full-year 2024, while maintaining annual revenue outlook ...
A new study shows that immunity after a COVID-19 booster lasts much longer than the primary series alone. These findings are among other, sometimes 'unintuitive,' revelations of how factors like age, ...
(Adds details on the approval, background and other details from paragraph 2) April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's drug for treating ...
BioNTech is a biotech company with a strong cash position and a commercial program generating cash flow, making it a promising investment opportunity. The company's pipeline includes programs ...
Pfizer, Inc. on Wednesday forecast 2024 sales ... News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine ...
(Adds details on the approval, background and other details from paragraph 2) April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's drug for treating ...
The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech ... but hasn't provided an update on the programme since then.